Martin Pharmaceuticals
Focus: Martin Pharmaceuticals specializes in drug repurposing with a focus on neurology, headquartered in New York. The company operates a modest pipeline across multiple therapeutic areas with limited public visibility on scale and financials.
Profile data last refreshed 3h ago · AI intelligence enriched 1w ago
Open Jobs
0
About Martin Pharmaceuticals
AI assessmentNot HiringNo open roles listed right now. Follow Martin Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Martin Pharmaceuticals's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
50 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Peak
Multiple regulatory pathways (NDA) suggest broad market presence across diagnostic imaging applications.
Help build intelligence for Martin Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.